Main Article Content
Background: The World Health Organisation in December, 2019 declared COVID-19 pandemic a disease of public health importance. It is however predicted by experts that the COVID-19 disease will eventually become an endemic disease, once enough people have developed immunity to COVID-19 either through vaccination or infection. The infection caused by the virus produce symptoms which necessitates professional healthcare. Pharmacists are frontline health care workers, often the fifirst port of call by patients when unwell. Knowledge of pharmacists impart on patient care and public health dissemination of information. This study assessed knowledge and practice of pharmacists in Nigeria with regards to COVID-19 disease.
Methods:Anationwide cross-sectional study was conducted among pharmacists in different practice settings in Nigeria using a snowball sampling technique. Pharmacists' demography, knowledge and practice due to COVID-19 pandemic was obtained with the aid of a semi- structured online questionnaire. Data collected were subjected to descriptive analysis. Each correct answer in the different subthemes generated was scored and transformed into ranges and percentiles.
Results: A total of 386 pharmacists were included in the study, majority of whom practiced in the hospital and administrative settings (31.9%). There were more males (50.3%) than females. Over 90% of respondents had good knowledge of COVID-19 disease. The mean knowledge score for mode of transmission of the disease and symptoms produced by the infection were 5.35 0.9 and 11.26 1.9 respectively. Similarly, pharmacists had a good practice towards Covid-19 disease. Mean score for practice towards the disease was 6.43 0.9. Majority (75.9%) however, had to provide their personal protective equipment.
Conclusion: These findings demonstrated that pharmacists had both good knowledge and practice towards the COVID-19 disease. This confirms pharmacists as a good resource for knowledge, which can be disseminated to patients and others during pandemics, or as the need arises.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Wu Y, Chen C, Chan Y (2020). The outbreak of COVID-19: An overview, Journal of the Chinese Medical Association. 83(3) 217 - 220 https://doi.org/10.1097/JCMA.0000000000000270
World Health Organization (2020). Coronavirus disease 2019 (COVID-19) Situation Report-161. Retrieved 29 June 2020, from https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200629-covid-19-sitrep-161.pdf?sfvrsn=74fde64e_2
Weis SR. (2020). Forty years with coronaviruses. Journal of Experimental Medicine, 217 (5), Article e20200537. https://doi.org/10.1084/jem.20200537
World Health Organization (2020). Coronavirus disease 2019 (COVID-19) Situation Report-161. Retrieved 29 June2020, from https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200629-covid-19-sitrep-161.pdf?sfvrsn=74fde64e_2
Nigeria Centre for Disease Control. (2020). National interim guidelines for clinical management of COVID-19 version 1. Retrieved 16 April 2020 https://www.ncdc.gov.ng
Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76, 71-76. https://doi.org/10.1016/j.ijsu.2020.02.034
Nigeria Centre for Disease Control (2020) COVID-19 situation report 122. Retrieved 29 June 2020, from https://www.ncdc.gov.ng/diseases/sitreps
International Pharmaceutical Federation (FIP). (2020). Coronavirus/COVID-19 preparedness. Retrieved 05 April 2020, from Available on: https://www.fip.org/coronavirus
Bukhari N, Rasheed H, Nayyer B, and Babar Z. (2020). Pharmacists at the frontline beating the COVID-19 pandemic. Journal of Pharmaceutical Policy and Practice 13, 8-8.
American Pharmacist Association. (2020). Pharmacists' Guide to Coronavirus. Retrieved 2020, July 02, from
Raosoft (2004). Raosoft Sample Size Calculator. Raosoft, Inc., Seattle. http://www.raosoft.com/samplesize.html
FIP (International Pharmaceutical Federation). (2020) COVID-19: Guidelines for Pharmacists and the Pharmacy workforce. Available at: https://www.fip.org/files/content/priority- areas/coronavirus/COVID-19- Guidelines-forpharmacists-and-thepharmacy-workforce.pdf Accessed 24/8/20.
UpToDate. Clinical Effectiveness COVID-19 Resources Available to All. Available at: www.uptodate.com. Accessed
World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Accessed 11/05/2020
Guerci C, Maffioli A, Bondurri AA, Ferrario L, Lazzarin F, Danelli P. (2020). COVID-19: How can a department of general surgery survive in a pandemic? Surgery 167(6):909-911
Al-Quteimat OM and Amer AM. (2020). SARS-CoV-2 outbreak: how can pharmacists help? Research in Social and Administrative Pharmacy 17 (2); 480-482
Hussain I, Majeed A, Saeed H, Hashmi FK, Imran I, Akbar M. (2020) A national study to assess pharmacists' preparedness against COVID-19 during its rapid rise period in Pakistan. PLoS ONE 15(11): e0241467.
Zeenny RM, Ramia E, Akiki Y, Salameh P. (2020). Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional study. Journal of Pharmaceutical Policy and Practice 13, 54
Saqlain M, Munir MM, Rehman SU, Gulzar A, Naz S, Ahmed Z, Tahir AH, Mashhood M. (2020). Knowledge, attitude, practice and perceived barriers among healthcare professionals regarding COVID-19: a cross-sectional survey from
Pakistan. Journal of Hospital Infection 105(3): 419 - 423. https://doi.org/10.1016/j.jhin.2020.05.007
Ghaibi S, Ipema H, Gabay M (2015). American Society of Health System P. ASHP guidelines on the pharmacist's role in providing drug information. American Journal of Health System Pharmacists 72(7):573–7
Joda AE, Olugbake OA, Oyetunde OO, Awofisayo O, Ibrahim M, Williams FE, Ayeni FA, Mosanya AU and Ologunagba MO. Pharmacists' Perception of their Roles and Involvement in Coronavirus Disease 2019 (COVID-19). Journal of Basic and Social Pharmacy Research, 2020;1(Supplement 1): S68-S82
Tesfaye ZT, Yismaw MB, Negash Z, Ayele AG. (2020). COVID-19-related knowledge, attitude and practice among hospital and community pharmacists in Addis Ababa, Ethiopia. Integrated Pharmacy Research and Practice (9):105–112
Yimenu DK, Demeke CA, Kasahun AE, Asrade S, Mekuria AB. (2020). COVID-19: What should health professionals know? Assessment of Knowledge, attitude, and practice of community pharmacists in a developing country. SAGE Open
Medicine Nov 16;8:2050312120973498. https://doi.org/10.1177/2050312120973498
Bhagavathula AS, Aldhaleei WA, Rahmani J, Mahabadi MA, Bandari DK. (2020). Knowledge and Perceptions of COVID-19 Among Health Care Workers: Cross-Sectional Study. JMIR public health and surveillance, 6(2), e19160.
Mbachu CNP, Azubuike CM, Mbachu II, Ndukwu CI, Ezeuko AY, Udigwe IB, Nnamani CP, Umeh UM, Ezeagwuna DA, Onah SK, Eze HO, Okereke UC, Orji-Ifeanyi EN. (2020). COVID-19 infection: Knowledge, attitude, practices, and impact among healthcare workers in a South-Eastern Nigerian state. J Infect Dev Ctries.;14(9):943-952.
Wondmkun YT and Mohammed OA. (2020). A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment. Biologics: Targets & Therapy. 14:77 - 82. https://doi.org/10.2147/BTT.S266487
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. (2020) Pharmacologic Treatments for Coronavirus Disease (2019) (COVID-19): A Review. JAMA. 323 (18): 1824 – 1836. https://doi.org/10.1001/jama.2020.6019
Rabby, MII. (2020). Current drugs with potential for treatment of COVID-19: A literature review. Journal of Pharmacy & Pharmaceutical Sciences, 23(1), 58–64.